While we here demonstrated a modulatory role of NLRP3–ASC inflammasome in transgenic mice in vivo, it remains to be considered whether conditions in AD patient brains are compatible with Tau-seed induced inflammasome activation. The gene discussed is MAPT; the disease is Alzheimer disease.